(ARTL) Artelo Biosciences - Performance 213.3% in 12m
ARTL performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-78.03%
#157 in Peer-Group
Rel. Strength
97.83%
#167 in Stock-Universe
Total Return 12m
213.32%
#5 in Peer-Group
Total Return 5y
-78.78%
#137 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 28.50 USD |
| 52 Week Low | 4.93 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 96.97 |
| Buy/Sell Signal +-5 | -3.57 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ARTL (213.3%) vs XLV (-6.7%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
0.9% | 131% | 354% | 62.6 | 55.3 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
2.5% | 13.5% | 82% | 19.4 | 14.7 | 1.44 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
-1.93% | -14.5% | 419% | 63.7 | 35.8 | 1.2 | 58.2% | 18.9% |
| NOVN SW Novartis |
-0.79% | 0.39% | 50.8% | 19.5 | 14.7 | 1.44 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-8.02% | 2.74% | 50.2% | 19.1 | 8.73 | 0.38 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
-3.54% | -6.89% | 49.9% | 27.9 | 15.4 | 0.93 | 72.4% | 45.1% |
| SFZN SW Siegfried Holding |
-6.74% | -9.61% | 106% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| UCB BR UCB |
3.73% | 19% | 62.6% | 31.1 | 22 | 1.04 | -22.4% | 39.5% |
Performance Comparison: ARTL vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for ARTL
| Total Return (including Dividends) | ARTL | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 231.60% | 0.06% | 4.01% |
| 3 Months | 384.14% | -0.76% | 17.14% |
| 12 Months | 213.32% | -6.69% | 13.46% |
| 5 Years | -78.78% | 44.47% | 112.73% |
| Trend Score (consistency of price movement) | ARTL | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 71.8% | 32.3% | 90.3% |
| 3 Months | 61% | -15.4% | 97.5% |
| 12 Months | -50.4% | -78.9% | 46.4% |
| 5 Years | -95.8% | 87.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th100.00 | 231.39% | 218.81% |
| 3 Month | %th100.00 | 387.83% | 313.29% |
| 12 Month | %th98.50 | 235.79% | 176.14% |
| 5 Years | %th29.50 | -85.31% | -90.02% |
FAQs
Does Artelo Biosciences (ARTL) outperform the market?
Yes,
over the last 12 months ARTL made 213.32%, while its related Sector, the Health Care Sector SPDR (XLV) made -6.69%.
Over the last 3 months ARTL made 384.14%, while XLV made -0.76%.
Performance Comparison ARTL vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ARTL vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 66.3% | 227.6% | 238.1% | 200% |
| US NASDAQ 100 | QQQ | 66.3% | 227.4% | 236.1% | 200% |
| German DAX 40 | DAX | 65.9% | 230.4% | 226% | 183% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 65.1% | 227.1% | 233.7% | 195% |
| Hongkong Hang Seng | HSI | 65.4% | 228.8% | 216.1% | 178% |
| India NIFTY 50 | INDA | 67.6% | 232.4% | 237.7% | 216% |
| Brasil Bovespa | EWZ | 70.5% | 232.2% | 223.1% | 212% |
ARTL vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 67.7% | 229.9% | 234.8% | 190% |
| Consumer Discretionary | XLY | 65.3% | 228.3% | 245.8% | 195% |
| Consumer Staples | XLP | 68.3% | 231.7% | 239.1% | 206% |
| Energy | XLE | 63.3% | 227.5% | 245.7% | 211% |
| Financial | XLF | 67.7% | 229% | 235.8% | 188% |
| Health Care | XLV | 66.1% | 231.5% | 249.6% | 220% |
| Industrial | XLI | 65.9% | 227.2% | 232.3% | 190% |
| Materials | XLB | 65.6% | 227.1% | 237.5% | 209% |
| Real Estate | XLRE | 66.5% | 231.7% | 239.6% | 205% |
| Technology | XLK | 66.4% | 225% | 233% | 202% |
| Utilities | XLU | 66.2% | 229% | 234.1% | 193% |
| Aerospace & Defense | XAR | 65.6% | 224.8% | 218.1% | 164% |
| Biotech | XBI | 62.6% | 228.5% | 248.4% | 224% |
| Homebuilder | XHB | 63.2% | 222.8% | 244.7% | 214% |
| Retail | XRT | 66.3% | 228.4% | 242.9% | 207% |
ARTL vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 65.7% | 228% | 252% | 218% |
| Natural Gas | UNG | 68% | 238.1% | 264.1% | 215% |
| Gold | GLD | 66.1% | 231.4% | 220.2% | 175% |
| Silver | SLV | 61.9% | 225.3% | 216.1% | 191% |
| Copper | CPER | 55.9% | 216.6% | 218.6% | 190% |
ARTL vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 67.1% | 231.6% | 243.4% | 218% |
| iShares High Yield Corp. Bond | HYG | 66.8% | 230.5% | 241.1% | 204% |